🇫🇷
France · FR · FR:60150015
RAVICTI 1,1 g/ml, liquide oral
ATC A16AX09
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerIMMEDICA PHARMA (SUEDE)
CountryFR (France)
ATC codeA16AX09
Dispensing—
ReimbursedNo
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 1
- cip1334009300956691 flacon en verre de 25 mL avec fermeture de sécurité enfant
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "60150015",
"date_amm": "2015-11-27",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/15/1062",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "liquide",
"voies_administration": "gastro-entérale;orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}Related drugs
Other records sharing ATC code A16AX09.
- 🇺🇸glycerol phenylbutyrateLupin Pharmaceuticals, Inc.
- 🇺🇸Glycerol phenylbutyrateNovadoz Pharmaceuticals LLC
- 🇺🇸Glycerol phenylbutyrateTeva Pharmaceuticals, Inc.
- 🇺🇸Glycerol PhenylbutyratePar Health USA, LLC
- 🇺🇸Glycerol PhenylbutyrateZydus Pharmaceuticals USA Inc.
- 🇺🇸Glycerol PhenylbutyrateAurobindo Pharma Limited
- NORavictiImmedica Pharma AB (1)
- 🇺🇸RavictiHorizon Therapeutics USA, Inc.
Access this data programmatically
Query RAVICTI 1,1 g/ml, liquide oral and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.